Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Laser Photonics Corp received a deficiency notice from Nasdaq on October 20, 2026, for failing to maintain a minimum bid price of $1.00 per share for 30 consecutive business days. The company has 180 calendar days, until April 19, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for at least 10 consecutive business days.
Unusual Machines Signs $52M M&A Deal with DroneNX LLC d/b/a Upgrade Energy
Unusual Machines completed its acquisition of DroneNX LLC (Upgrade Energy), a U.S. manufacturer of high-performance drone batteries and power systems. The total consideration includes $25 million in common stock, $1 million in cash at closing, and a potential $26 million earn-out based on future revenue targets. The deal expands the company's portfolio of NDAA-compliant drone components to include critical battery and power systems.
Arcus Biosciences completed a public offering of 16,428,572 shares of common stock, including the full exercise of the underwriters' option to purchase additional shares. The offering was priced at $17.50 per share, resulting in net proceeds of approximately $269.7 million after fees and expenses.
Value
$288M
Counterparty
Jefferies LLC, Leerink Partners LLC and TD Securities (USA) LLC
Citius Oncology received a formal extension from Nasdaq until April 19, 2027, to regain compliance with the $1.00 minimum bid price requirement. To satisfy the rule, the company's common stock must close at or above $1.00 for at least ten consecutive business days. The stock continues to trade on the Nasdaq Capital Market under the symbol 'CTOR' while the company evaluates options to address the deficiency.
Melar Acquisition Corp. I M&A Deal with Everli Global Inc.
Melar Acquisition Corp. I shareholders approved its proposed business combination with Everli Global Inc., an e-grocery technology and fulfillment platform in Italy. Following the closing, the combined company will operate as Everli Global Holdings Inc. and trade on Nasdaq under the ticker 'EVRL'.
Jewett Cameron Trading Co Divestiture to Washington County for $5.9M
Jewett-Cameron Trading Company's subsidiary, JC USA Inc., entered into a definitive agreement to sell its surplus seed property in Hillsboro, Oregon, to Washington County for $5.9 million. The transaction is subject to a 180-day due diligence period and approval by the Washington County Board of Commissioners. Proceeds from the sale will be used to reduce any outstanding amounts under the company's credit facility, though no amounts are currently outstanding.
Novagold Resources M&A Deal with Paulson Advisers LLC
NOVAGOLD provided a status update on its pending acquisition of the remaining 40% interest in Donlin Gold LLC from Paulson Advisers LLC. The company issued supplemental disclosures to its proxy statement to address demand letters from purported shareholders and avoid potential litigation delays ahead of the November 3, 2026, shareholder vote. Upon completion, NOVAGOLD will increase its ownership in Donlin Gold from 60% to 100% in an all-share transaction.
Sunrise Realty Trust M&A Deal with Southern Realty Trust Inc.
Sunrise Realty Trust stockholders approved the issuance of approximately 8.46 million shares for its pending merger with Southern Realty Trust Inc. The merger, which has now received approval from both companies' stockholders, is expected to close on November 5, 2026, creating a larger Nasdaq-listed commercial real estate lending platform.
Stem, Inc. received a non-compliance letter from the NYSE because its average global market capitalization and stockholders' equity both fell below the $50 million minimum requirement over a 30 trading-day period. The company intends to submit a business plan within 45 days detailing how it will regain compliance within the 18-month cure period. The company's common stock will continue to trade on the NYSE during this period, subject to the exchange's acceptance of the plan.
Akebia Therapeutics received a deficiency notice from Nasdaq because its common stock closed below the $1.00 minimum bid price for 30 consecutive business days. The company has until April 19, 2027, to regain compliance, which requires the stock to close at $1.00 or higher for at least 10 consecutive business days. Akebia is evaluating options to cure the deficiency, including a potential reverse stock split.
MacroGenics announced positive interim Phase 1 data for MGC026, a B7-H3-directed antibody-drug conjugate, in patients with advanced solid tumors. The study showed a 27% best overall response rate in heavily pretreated SCCHN patients and a manageable safety profile with no treatment-related discontinuations in that cohort. Based on these results, the company plans to initiate a front-line combination study evaluating MGC026 with pembrolizumab.
Polar Power, Inc. is providing an update on its efforts to regain compliance with Nasdaq's minimum stockholders' equity requirement of $2.5 million. The company has until October 28, 2026, to demonstrate compliance and has executed several financings, including convertible notes and Series A Preferred Stock issuances, to bolster its equity position. These transactions, along with an equity line of credit with Roth Principal Investments, are intended to meet the Nasdaq Capital Market's continued listing standards.
High Roller Technologies has commercially launched ROLR™, its real-money prediction markets platform, for eligible U.S. customers following a successful beta period. The platform offers event-based contracts through a partnership with Crypto.com | Derivatives North America (CDNA) and is expected to begin generating revenue in Q4 2026.
Counterparty
Crypto.com | Derivatives North America
“Today’s full commercial launch of our prediction markets platform is a defining milestone for High Roller as we bring ROLR to the public and begin the next phase of our growth.”
Seth Young, Chief Executive Officer of High Roller Technologies
“Our goal is to make prediction markets accessible and engaging through an intuitive customer experience, and our experience operating real-money consumer platforms provides a strong foundation for building this business.”
Seth Young, Chief Executive Officer of High Roller Technologies
Amneal Pharmaceuticals M&A Deal with Kashiv BioSciences, LLC
Amneal Pharmaceuticals filed an amendment to its previous 8-K to provide required historical financial statements and pro forma financial information following its completed acquisition of Kashiv BioSciences, LLC. The acquisition was originally completed on August 10, 2026, pursuant to a Membership Interest Purchase Agreement dated April 21, 2026.
Red Cat Holdings, through its subsidiary SMOT Acquisition GmbH, has launched a voluntary public cash tender offer to acquire all outstanding shares of Austrian engine manufacturer Steyr Motors AG for EUR 39.00 per share. The transaction is intended to strengthen Red Cat's 'Blue Ops' uncrewed surface vessel (USV) strategy by integrating Steyr's marine engine technology and European manufacturing base.
Counterparty
Steyr Motors AG
“This proposed transaction is about investing in that foundation and helping Steyr Motors grow. We see Austria as central to the future of the business, and our goal is to provide additional resources, customer access and long-term demand that can support Steyr Motors’ employees, operations and continued expansion.”
Jeff Thompson, Chief Executive Officer of Red Cat
“Four years into Steyr Motors’ transformation, I am very excited to lead its next chapter with Red Cat as strategic partner on our side. Our engineering and Red Cat’s reach into international markets are the basis for joint growth, and Red Cat stands firmly behind our site and our people.”
Reliance Global Group M&A Deal with Steyr Motors AG
Red Cat Holdings announced a voluntary public purchase offer to acquire all outstanding shares of Steyr Motors AG for EUR 39.00 per share in cash. The deal is intended to strengthen Red Cat's autonomous maritime portfolio by integrating Steyr's marine engine technology and European manufacturing base.
Nathans Famous M&A Deal with Smithfield Foods, Inc.
Stockholders of Nathan’s Famous, Inc. approved the previously announced merger agreement with Smithfield Foods, Inc. at a special meeting held on October 23, 2026. Under the agreement, Nathan’s will become a wholly-owned subsidiary of Smithfield Foods following the completion of the merger.
Valor Energy Inc entered into a securities purchase agreement to sell 2,145,923 shares of common stock in a private placement. The offering is expected to generate gross proceeds of approximately $5.0 million. The company intends to use the net proceeds for AI data center project development and general corporate purposes.
Blue Owl Credit Income Corp. sold 464,303 unregistered shares of Class I common stock for approximately $4.26 million in a private offering to feeder vehicles. The company also reported that its continuous public offering has raised over $22.49 billion in total consideration to date across all share classes.
1 800 Flowers Com Divestiture to PlanetArt, LLC for $45M
1-800-FLOWERS.COM completed the sale of its Personalization Businesses, including Personalization Mall, Things Remembered, and Personalization Universe, to PlanetArt, LLC for $45.0 million in cash. The company used a portion of the net proceeds to prepay outstanding term loans under its existing credit facility.
Blackstone Private Real Estate Credit & Income Fund Capital Raise of $2.73M
Blackstone Private Real Estate Credit and Income Fund sold 104,054 unregistered common shares of beneficial interest to investors in a private placement. The transaction, finalized on October 21, 2026, raised approximately $2.73 million in gross proceeds. The offering was conducted under exemptions from registration provided by Section 4(a)(2) and Regulation D/S of the Securities Act.
EQT Infrastructure Company LLC sold 3,147,858 unregistered shares to third-party investors for aggregate cash consideration of approximately $92.1 million. The shares were sold at a price equal to the transactional net asset value per share as part of the company's continuous private offering, which has raised over $1.1 billion since inception in February 2026.
EQT Private Equity Company LLC sold 663,060 unregistered shares to third-party investors for aggregate cash consideration of approximately $19.1 million. The shares were sold across multiple classes (Class I, J1, J2, and S) at prices based on the company's Transactional Net Asset Value per share. Since its inception in July 2025, the company has raised approximately $880.2 million through its continuous private offering.
Zevia PBC entered into a securities purchase agreement with Bubble Holdings, LLC (an affiliate of GP Investments, Ltd.) to raise up to $20 million through the issuance of Series A Senior Convertible Preferred Stock. The company completed an initial closing of $15 million on October 22, 2026, with a deferred closing of $5 million contingent on meeting specific 2026 net sales and Adjusted EBITDA targets.
Value
$15M
Counterparty
Bubble Holdings, LLC
“This growth equity investment marks an important milestone in Zevia’s evolution and provides the capital, strategic resources, and operational expertise to accelerate our medium- and long-term growth agenda.”
“We are thrilled to partner with Zevia and help support accelerated profitable growth. The team’s execution strengths and clear growth plan give us confidence in Zevia’s potential to become a leading everyday alternative to traditional soda, as consumers increasingly seek healthier options without artificial sweeteners.”
Ionis Pharmaceuticals and its partner Roche announced positive Phase 3 IMAgINATION study results for sefaxersen in patients with IgA nephropathy. The trial met its primary endpoint, demonstrating a statistically significant 43.1% reduction in proteinuria compared to placebo at 37 weeks, with a safety profile consistent with earlier studies.
Counterparty
Roche
“These data support our belief that sefaxersen is uniquely positioned to treat IgA nephropathy, demonstrating significant and clinically meaningful reduction in proteinuria and offering the potential to help reduce the need for long-term dialysis or kidney transplantation.”
Brett P. Monia, Ph.D., chief executive officer, Ionis
“Sefaxersen is a powerful example of the broad impact of Ionis' innovative science, and based on these positive data, we believe it has the potential to be an important new treatment option for people living with IgA nephropathy.”
Brett P. Monia, Ph.D., chief executive officer, Ionis
Lord Abbett Private Credit Fund Capital Raise of $34.1M
Lord Abbett Private Credit Fund issued and sold approximately 1.37 million common shares for aggregate proceeds of $34.1 million. The private placement was conducted at a price of $24.86 per share and was exempt from registration under Section 4(a)(2) and Regulation D. The fund also provided a portfolio update showing $2.36 billion in total loan commitments across 70 portfolio companies.
T3 Defense Inc. announced it has regained compliance with Nasdaq's minimum stockholders' equity requirement of $10 million. The company resolved a previous deficiency caused by the non-cash liability classification of warrants, which had temporarily driven stockholders' equity into a deficit. Following the exercise of 96% of those warrants, the company reported pro forma stockholders' equity of approximately $99.9 million as of September 30, 2026.
Worthington Steel provided a status update on its acquisition of Kloeckner & Co SE, noting that a proposed domination and profit and loss transfer agreement (DPLTA) failed to receive required shareholder approval. Despite the vote, Worthington Steel remains the majority owner with a 62% stake and will continue to consolidate Kloeckner's financial results while pursuing synergies under the existing governance structure.
Vista Credit Strategic Lending Capital Raise of $7.23M
Vista Credit Strategic Lending Corp. sold 371,804.601 shares of its Class I common stock for total consideration of approximately $7.23 million. The unregistered sale was conducted via subscription agreements with accredited investors and non-U.S. persons. The company also reported a preliminary net asset value (NAV) per share of $19.44 as of September 30, 2026.
BancFirst Corporation completed the acquisition of Spirit BankCorp, Inc. and its subsidiary SpiritBank, a privately held community bank headquartered in Tulsa, Oklahoma. SpiritBank, which has approximately $866.8 million in total assets and $776.4 million in deposits, was merged into BancFirst upon the closing of the transaction.